Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD99-mediated immunological synapse formation potentiates CAR-T cell function.

Nature communications·2025
Same author

Vaccine Strategy That Enhances the Protective Efficacy of Systemic Immunization by Establishing Lung-Resident Memory CD8 T Cells Against Influenza Infection.

Immune network·2023
Same author

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy.

Science advances·2022
Same author

A "Prime and Deploy" Strategy for Universal Influenza Vaccine Targeting Nucleoprotein Induces Lung-Resident Memory CD8 T cells.

Immune network·2021
Same author

MHC multimer: A Molecular Toolbox for Immunologists.

Molecules and cells·2021
Same author

Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.

PloS one·2019
Same journal

In Search of Adaptive-Like Features of NK Cells Co-Expressing NKG2C and NKG2A.

Immune network·2026
Same journal

Immunosenescence and Cancer: Cellular Aging Programs That Reshape Antitumor Immunity.

Immune network·2026
Same journal

Complement Anaphylatoxin C5a-Induced Mouse Lymphatic Functions Modulate Interactions Between Endothelial Cells and T Lymphocytes.

Immune network·2026
Same journal

Defining PI3K Signaling as a Key Regulator of Molecular Heterogeneity and Inflammation in Glomerular Lupus Nephritis.

Immune network·2026
Same journal

Beyond Perineural Drainage: Revisiting the Olfactory Nerve as an Active Immunological Interface During Neuroinflammation.

Immune network·2026
Same journal

Cigarette Smoke Induces the Pro-inflammatory Response of Lung Macrophages via Activation of the IL-33/ST2-Dependent Pathway.

Immune network·2026
See all related articles

Related Experiment Video

Updated: Nov 12, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.6K

Adenovirus Vectors: Excellent Tools for Vaccine Development.

Jun Chang1

  • 1Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.

Immune Network
|March 17, 2021
PubMed
Summary
This summary is machine-generated.

Adenovirus vectors are increasingly used for vaccines against infectious diseases and cancer. This review discusses their immunological properties and advancements in developing safer, more effective adenovirus-based vaccines.

Keywords:
AdenovectorAdenovirusGenetic vectorVaccine

More Related Videos

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

7.4K
An Efficient Method for Adenovirus Production
10:06

An Efficient Method for Adenovirus Production

Published on: June 10, 2021

14.6K

Related Experiment Videos

Last Updated: Nov 12, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.6K
Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

7.4K
An Efficient Method for Adenovirus Production
10:06

An Efficient Method for Adenovirus Production

Published on: June 10, 2021

14.6K

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Adenovirus vectors were initially developed for gene therapy.
  • Recent advancements have enhanced their safety and immunogenicity for vaccine applications.
  • Adenovirus vectors are now explored for both infectious disease and cancer vaccines.

Purpose of the Study:

  • To review the immunological characteristics of adenovirus vectors.
  • To examine the current status of adenovirus-based vaccine development.
  • To discuss strategies for overcoming limitations of current adenovirus vaccine vehicles.

Main Methods:

  • Literature review of adenovirus vector applications in vaccinology.
  • Analysis of innate and adaptive immune responses to adenovirus vectors.
  • Evaluation of current and emerging adenovirus-based vaccine technologies.

Main Results:

  • Adenovirus vectors exhibit significant potential as vaccine platforms.
  • Next-generation vectors show improved safety and immunogenicity profiles.
  • Ongoing research focuses on optimizing adenovirus vectors for diverse therapeutic applications.

Conclusions:

  • Adenovirus vectors are promising tools for developing novel vaccines.
  • Further research and development are crucial for realizing their full potential.
  • Optimized adenovirus-based vaccines could accelerate prevention of infectious diseases and treatment of cancers.